GSK to sell entire 4.2% remaining stake in Haleon

16th May 2024 17:02

(Sharecast News) - GSK said on Thursday that it plans to sell its entire remaining 4.2% stake in Haleon.

The pharmaceutical company will sell about 385m ordinary shares in consumer health business Haleon, which it spun off in July 2022.

GSK initially retained a 12.9% stake in Haleon, but has since sold stakes in May 2023, October 2023 and January 2024.

The final disposal will be conducted through a placing of ordinary shares to institutional investors. GSK said the offer price will be determined by means of an accelerated bookbuild offering process which will start immediately.

Top Risers

Share	Price	Change
Tt Electronics (TTG)	108.50	37.34%
GreenRoc Strategic Materials (GROC)	1.55	14.81%
Angle (AGL)	11.25	12.5%
Pantheon Resources plc (PANR)	26.85	9.37%
Aptamer Group (APTA)	0.30	9.09%

Top Fallers

Share	Price	Change
Solid State (SOLI)	142.50	-32.94%
TekCapital (TEK)	7.85	-21.5%
Altitude Group (ALT)	29.00	-14.71%
Electric Guitar (ELEG)	0.325	-13.33%
Volex (VLX)	299.00	-12.95%

Top By Volume

Share	Price	Volume
Tower Resources (TRP)	0.0295	456,924,706
Inspirit Energy (INSP)	0.003	153,266,833
Cap-xx (CPX)	0.135	82,565,947
Mosman Oil Gas (MSMN)	0.0435	79,873,342
88 Energy (88E)	0.0875	51,091,001

All prices are delayed by at least 15 minutes. Share Compare cannot be held responsible for the accuracy of share prices shown on this website, and investors should be aware that share prices can go down as well as up. Share Compare does not offer advice, and is not regulated by the Financial Conduct Authority.